Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Environmental Monitoring in Dispensing Rooms – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Environmental Monitoring in Dispensing Rooms – V 2.0

Standard Operating Procedure for Environmental Monitoring in Dispensing Rooms


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/106/2025
Supersedes SOP/SIM/106/2022
Page No. Page 1 of 12
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To establish a procedure for environmental monitoring of dispensing rooms used in sterile injectable manufacturing to ensure compliance with GMP requirements and maintenance of cleanroom standards.

2. Scope

This SOP applies to all dispensing rooms classified as controlled environments (Grade C/D) in sterile injectable production

facilities.

3. Responsibilities

  • Microbiology Analyst: Responsible for conducting environmental monitoring and recording results.
  • QA Executive: Reviews reports and assesses compliance with limits.
  • Production Supervisor: Ensures area readiness and supports monitoring schedule.
See also  Manufacturing Operations: SOP for Sterile Handling of Ampoules during Manufacturing - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for implementation and compliance.

5. Procedure

5.1 Parameters to Monitor

  • Non-viable particle count
  • Viable microbial count (air and surface)
  • Temperature and relative humidity
  • Differential pressure

5.2 Frequency of Monitoring

  • Non-viable particles: Daily (before start of dispensing)
  • Viable monitoring: Weekly (air settle plates and contact plates)
  • Temperature & RH: Continuous digital logging
  • Differential Pressure: Daily and continuous with alarms

5.3 Sampling Locations

Defined as per Dispensing Area Layout (Annexure-1). Minimum of 3 locations per dispensing room, including near balance, entrance, and material transfer area.

5.4 Limits and Alerts

Acceptable limits shall be as per ISO 14644 and EU GMP Annex 1 (Annexure-2). Any deviation must be investigated and documented.

See also  Sterile Injectable Manufacturing: SOP for Setting Parameters for Vial Filling Machines - V 2.0

5.5 Action on Deviations

  1. Immediately inform QA and stop dispensing operations.
  2. Initiate deviation report (Annexure-3).
  3. Perform additional cleaning and repeat monitoring.
  4. Resume activity only after QA approval.

6. Abbreviations

  • RH: Relative Humidity
  • GMP: Good Manufacturing Practice
  • SOP: Standard Operating Procedure

7. Documents

  1. Dispensing Area Layout – Annexure-1
  2. Environmental Limits Reference Table – Annexure-2
  3. Deviation Report Format – Annexure-3
  4. Environmental Monitoring Logbook – Annexure-4

8. References

  • EU GMP Annex 1
  • ISO 14644 Cleanroom Standards
  • Internal Microbiology SOPs

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Microbiologist QA Executive Head QA
Department Quality Control Quality Assurance Quality Assurance
See also  In-Process Control: SOP for Real-Time Monitoring of Vial Fill Levels - V 2.0

11. Annexures

Annexure-1: Dispensing Area Layout

(Attach certified layout with sampling points marked)

Annexure-2: Environmental Limits Reference Table

Parameter Grade C Grade D
Particles ≥0.5 µm 352,000 3,520,000
Viable Airborne Microbes 100 CFU/m³ 200 CFU/m³
Surface Microbes 5 CFU/plate 50 CFU/plate

Annexure-3: Deviation Report Format

Include fields for date, monitoring parameter, observed deviation, root cause analysis, corrective actions, and approvals.

Annexure-4: Environmental Monitoring Logbook

Used for recording daily and weekly monitoring data including location, instrument ID, date, and analyst signature.

Revision History

Revision Date Revision No. Details Reason Approved By
15/02/2022 1.0 Initial release New SOP Head QA
18/06/2025 2.0 Updated with alarm integration and deviation form System Upgrade Head QA
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Environmental Monitoring in Gel Manufacturing Areas – V 2.0
Next Post: Biosimilars: SOP for Cell Retention System Use (ATF, TFF) – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version